Status:
TERMINATED
Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients
Lead Sponsor:
University Hospital, Lille
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Many studies have reported a disparity in medication adherence among epileptic patients. In this population, Medication Possession Ratio (MPR) is an index of medication adherence. MPR is defined as th...
Eligibility Criteria
Inclusion
- Epileptic patients seeing a neurologist in the neurophysiology clinic with a regular follow-up by the Lille University Hospital reference center
- Adult over 18 years old
- Living at home
- Socially insured patient
- In the case of cognitive problems, the presence of a reliable caregiver managing the medications
Exclusion
- Inpatients
- Patient under curatorship, guardianship and/or institutionalized
- Dementia
- Patient who has participated in a therapeutic education program (TEP) about his epilepsy within the previous two years
- Administrative reasons: impossibility to receive informed information, impossibility to participate in the entire study, lack of coverage by the social security system, refusal to sign the consent form.
- Switching to home care by a registered nurse for treatment management
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04876820
Start Date
October 1 2021
End Date
October 1 2024
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Roger Salengro, CHU Lille
Lille, France, 59037